The Daiichi deal will help the company emerge as a global research firm, says the Ranbaxy management, reports CNBC-TV18. Ranbaxy is expected to become a subsidiary of Daiichi. Daiichi will fund the stake buy via internal accruals and debt, added the Ranbaxy management
No comments:
Post a Comment